Literature DB >> 26341371

Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.

Marc C Chamberlain1,2, Donald Born3.   

Abstract

1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a <0.80 proportion with >30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance.

Entities:  

Keywords:  Oligodendroglioma; Polysomy; Relative1p/19q codeletion

Mesh:

Year:  2015        PMID: 26341371     DOI: 10.1007/s11060-015-1906-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

Review 1.  Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma.

Authors:  Michael Weller; Wolfgang Wick
Journal:  Nat Rev Neurol       Date:  2014-01-14       Impact factor: 42.937

2.  A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

Authors:  Robert B Jenkins; Hilary Blair; Karla V Ballman; Caterina Giannini; Robert M Arusell; Mark Law; Heather Flynn; Sandra Passe; Sara Felten; Paul D Brown; Edward G Shaw; Jan C Buckner
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Polysomy of chromosomes 1 and/or 19 is common and associated with less favorable clinical outcome in oligodendrogliomas: fluorescent in situ hybridization analysis of 84 consecutive cases.

Authors:  Andrea L Wiens; Liang Cheng; Elizabeth C Bertsch; Karen A Johnson; Shaobo Zhang; Eyas M Hattab
Journal:  J Neuropathol Exp Neurol       Date:  2012-07       Impact factor: 3.685

4.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

5.  Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Authors:  Martin J van den Bent; Alba A Brandes; Martin J B Taphoorn; Johan M Kros; Mathilde C M Kouwenhoven; Jean-Yves Delattre; Hans J J A Bernsen; Marc Frenay; Cees C Tijssen; Wolfgang Grisold; László Sipos; Roelien H Enting; Pim J French; Winand N M Dinjens; Charles J Vecht; Anouk Allgeier; Denis Lacombe; Thierry Gorlia; Khê Hoang-Xuan
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

6.  Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases.

Authors:  Xiaohui Ren; Haihui Jiang; Xiangli Cui; Yong Cui; Jun Ma; Zhongli Jiang; Dali Sui; Song Lin
Journal:  Neuro Oncol       Date:  2013-07-16       Impact factor: 12.300

7.  Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.

Authors:  Kenneth B Fallon; Cheryl A Palmer; Kevin A Roth; L Burton Nabors; Wenquan Wang; Mark Carpenter; Ruma Banerjee; Peter Forsyth; Keith Rich; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2004-04       Impact factor: 3.685

8.  Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors.

Authors:  Haihui Jiang; Xiaohui Ren; Zhe Zhang; Wei Zeng; Junmei Wang; Song Lin
Journal:  J Neurooncol       Date:  2014-07-10       Impact factor: 4.130

9.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

10.  Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.

Authors:  Matija Snuderl; April F Eichler; Keith L Ligon; Quynh U Vu; Michael Silver; Rebecca A Betensky; Azra H Ligon; Patrick Y Wen; David N Louis; A John Iafrate
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

  10 in total
  16 in total

1.  Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.

Authors:  P Darvishi; P P Batchala; J T Patrie; L M Poisson; M-B Lopes; R Jain; C E Fadul; D Schiff; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-23       Impact factor: 3.825

2.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

Review 3.  Recent advances and future of immunotherapy for glioblastoma.

Authors:  Neha Kamran; Alexandra Calinescu; Marianela Candolfi; Mayuri Chandran; Yohei Mineharu; Antonela S Asad; Carl Koschmann; Felipe J Nunez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Biol Ther       Date:  2016-07-27       Impact factor: 4.388

4.  MRI radiomics analysis of molecular alterations in low-grade gliomas.

Authors:  Ben Shofty; Moran Artzi; Dafna Ben Bashat; Gilad Liberman; Oz Haim; Alon Kashanian; Felix Bokstein; Deborah T Blumenthal; Zvi Ram; Tal Shahar
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-12-21       Impact factor: 2.924

5.  Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Authors:  Connor J Kinslow; Andrew L A Garton; Ali I Rae; Logan P Marcus; Christopher M Adams; Guy M McKhann; Michael B Sisti; E Sander Connolly; Jeffrey N Bruce; Alfred I Neugut; Adam M Sonabend; Peter Canoll; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-08-12       Impact factor: 4.130

6.  Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.

Authors:  P P Batchala; T J E Muttikkal; J H Donahue; J T Patrie; D Schiff; C E Fadul; E K Mrachek; M-B Lopes; R Jain; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2019-01-31       Impact factor: 3.825

7.  Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.

Authors:  Peter J Dickinson; Dan York; Robert J Higgins; Richard A LeCouteur; Nikhil Joshi; Danika Bannasch
Journal:  J Neuropathol Exp Neurol       Date:  2016-05-31       Impact factor: 3.685

8.  Brain cancer: Tumour cells on neighbourhood watch.

Authors:  Harald Sontheimer
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

9.  Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.

Authors:  Melike Pekmezci; Terri Rice; Annette M Molinaro; Kyle M Walsh; Paul A Decker; Helen Hansen; Hugues Sicotte; Thomas M Kollmeyer; Lucie S McCoy; Gobinda Sarkar; Arie Perry; Caterina Giannini; Tarik Tihan; Mitchel S Berger; Joseph L Wiemels; Paige M Bracci; Jeanette E Eckel-Passow; Daniel H Lachance; Jennifer Clarke; Jennie W Taylor; Tracy Luks; John K Wiencke; Robert B Jenkins; Margaret R Wrensch
Journal:  Acta Neuropathol       Date:  2017-03-02       Impact factor: 15.887

Review 10.  Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.

Authors:  Sebastian Brandner; Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Luke Vale; Julian P T Higgins; Kathreena M Kurian
Journal:  Neuropathol Appl Neurobiol       Date:  2022-03-03       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.